Dr. Tracy George stands in a laboratory. She smiles at the camera.

President and Chief Medical Officer Tracy George, MD, worked with ARUP’s PharmaDX and Clinical Trials group to create the central pathology review offering used in clinical trials for AYVAKIT. The new precision therapy for advanced systemic mastocytosis recently earned approval from the U.S. Food and Drug Administration.

July 2, 2021

ARUP’s Clinical Trials Group Lauds FDA Approval of New Precision

The FDA recently approved a new precision therapy developed by Blueprint Medicines for adults with advanced systemic mastocytosis, a rare and potentially fatal hematologic malignancy.

Adam Baker stands in a laboratory. He smiles at the camera.

Adam Barker, PhD, has been named ARUP’s first chief scientific officer. He moves into the role after having spent four years as director of Research and Development.

July 1, 2021

ARUP Appoints Adam Barker, PhD, to Lead Its New Technologies Group

Adam Barker, PhD, has been appointed as ARUP’s chief scientific officer, a role in which he will lead the newly formed New Technologies Group.

Jonathan Genzen, Sherrie L. Perkins, Andy Theurer, and Peter Jensen cut a red ribbon to officially open ARUP's new laboratory facility.

ARUP Chief Operations Officer Jonathan Genzen, MD, PhD (left), joined CEO Sherrie L. Perkins, MD, PhD, President Andy Theurer, and Board Chairman Peter Jensen, MD, on June 15, 2021, to cut a ceremonial ribbon to officially open ARUP’s new state-of-the-art laboratory facility in University of Utah Research Park.

June 15, 2021

ARUP Celebrates the Opening of a New State-of-the-Art Laboratory Facility in Salt

ARUP Laboratories, one of the nation’s largest reference laboratories, held a ribbon cutting ceremony to officially open its new four-story, 220,000-square-foot laboratory facility in Salt Lake City.

Image shows a microscopic view of circulating tumor cells.

Photo credit: kjpargeter - www.freepik.com

 
May 10, 2021

ARUP Announces Partnership with TellBio for Use of TellBio’s Novel

SALT LAKE CITY—ARUP Laboratories today announced it has signed a strategic agreement with Massachusetts-based TellBio Inc. to use the development-stage biotechnology company’s TellDx circulating tumor cells (CTCs) technology in several research applications.

Elizabeth L. Frank, PhD

April 28, 2021

ARUP Medical Director Earns AACC Award for Outstanding Contributions to

Elizabeth L. Frank, PhD, has earned the 2021Outstanding Contributions to Education in Clinical Chemistry Award from the American Association for Clinical Chemistry (AACC).

February 1, 2021

Ribbon-Cutting Ceremony Marks First Phase of ARUP’s Expansion into a New State-of-the-Art Facility

ARUP Laboratories marked an important milestone on February 1 with a ribbon-cutting ceremony broadcast via Facebook Live to celebrate the first-phase opening of its new 220,000-square-foot building. Upon its completion later this spring, the new building will add 140,000 square feet to ARUP’s laboratory operations, including 35,000 square feet for specimen processing and approximately 1.4 miles of